Yahoo! Finance: Top Stories

DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns

Apr 1, 2025 - 14:12
 0
DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns
Read More

Tags:

Previous Article

Weyerhaeuser Company (WY): A Bear Case Theory

Next Article

Taiwan Semiconductor Manufacturing Company Limited (TSM): A Bull Case Theory

Related Posts

How to Make 267%—or Lose 90%—on Treasury Bonds

How to Make 267%—or Lose 90%—on Treasury Bonds

Mar 28, 2025  0

Fed Decision; Nvidia Conference; FedEx Results: What to Watch in Markets This Week

Fed Decision; Nvidia Conference; FedEx Results: What to...

Mar 17, 2025  0

Nvidia-Backed CoreWeave Prices Its IPO at $40 Per Share, Below Expectations

Nvidia-Backed CoreWeave Prices Its IPO at $40 Per Share...

Mar 29, 2025  0